Initial experience with the intravascular contrast agent NC100150-injection (Clariscan) for breath-hold and navigator-gated magnetic resonance coronary artery imaging.
J Magn Reson Imaging
PURPOSE: To examine magnetic resonance coronary artery imaging after NC100150-Injection. MATERIALS AND METHODS: Breath-hold and navigator-gated images were acquired in five patients. RESULTS: Breath-hold image quality, coronary artery-fat SDNR, and coronary artery SNR improved. Respiratory artifacts due to reduced liver signal intensity degraded navigator-gated image quality. CONCLUSION: NC100150-Injection improves breath-hold coronary artery imaging. Navigator-gated acquisitions should use techniques that are insensitive to T2* effects.
|Title:||Initial experience with the intravascular contrast agent NC100150-injection (Clariscan) for breath-hold and navigator-gated magnetic resonance coronary artery imaging.|
|Keywords:||Aged, Contrast Media, Coronary Vessels, Dextrans, Ferrosoferric Oxide, Humans, Image Processing, Computer-Assisted, Iron, Magnetic Resonance Angiography, Magnetite Nanoparticles, Middle Aged, Oxides, Statistics, Nonparametric|
|UCL classification:||UCL > School of Life and Medical Sciences
UCL > School of Life and Medical Sciences > Faculty of Population Health Sciences
UCL > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science
Archive Staff Only